NHS Innovation Accelerator
Gavin Matthews is an accomplished entrepreneur and business leader with extensive experience in the healthcare and business development sectors. As the Founder and CEO of Quiddity Health since January 2020, Gavin has also served as a Fellow with the NHS Innovation Accelerator and as the UK Business Development Director at SkinVision. Previous roles include Interim Commercial Director at DrDoctor and various leadership positions at Synertec Ltd, including Head of Business Development and Head of Account Management. Gavin's career began with The Live Organisation, where important sales roles were held. Educational achievements include an Advanced Certificate in Coaching Practice from Mindful Talent and a degree in Economics with a focus on International Business from the University of the West of England. Further education was completed at Wargrave Piggott.
This person is not in the org chart
This person is not in any teams
NHS Innovation Accelerator
1 followers
The NHS Innovation Accelerator (NIA) is an NHS England Initiative delivered in partnership with the country’s 15 Health Innovation Networks (HINs) and the Accelerated Access Collaborative. Hosted by UCLPartners, it supports delivery of the Five Year Forward View by accelerating uptake of high impact innovations for patient, population and NHS staff benefit, and providing real time practical insights on spread to inform national strategy. Fellows supported by the NIA all share a set of values and passion for scaling evidence-based innovation to benefit a wider population, with a commitment to share their learnings. Some impressive results have been achieved by Fellows since the NIA launched in July 2015: 2,980 additional NHS sites now using NIA innovations; £203 million in external funds secured; 193 awards won; 1,145 jobs created; and 57 innovations selling internationally. In addition, impact data is already available at adopter sites and this demonstrates earlier intervention, reductions in complications and emergency admissions, alongside cost savings.